11/12/2024
12:44 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144/A | |
11/07/2024
4:24 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
3:27 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:07 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:09 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:06 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:22 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/15/2024
3:27 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
4:06 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
3:50 PM | Blueprint Medicines (Subject)
Lee Philina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:48 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:29 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
6:07 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:08 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:54 PM | Blueprint Medicines (Subject)
Durso-Bumpus Debra (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024
3:36 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/14/2024
4:32 PM | Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:32 PM | Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:34 PM | Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:34 PM | Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:35 PM | Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:36 PM | Blueprint Medicines (Issuer)
Tsai John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:37 PM | Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:38 PM | Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:41 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:11 PM | Blueprint Medicines (Subject)
Carter Percy H. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
3:40 PM | Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
Hewes L. Becker (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:38 PM | Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
7:00 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:19 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:26 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:43 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
6:09 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:09 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
4:24 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/25/2024
4:25 PM | Blueprint Medicines (Filer)
| Form ARS | |
04/25/2024
7:30 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
11:58 AM | Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A | |
03/28/2024
4:57 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
8:11 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:50 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Tesla Trade Is Back In Business (Ad) If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows…
But according to our one expert, new yearly highs are on the horizon…
In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker.
Which is why we’re emailing you now…
You see, most people will simply buy shares of Tesla ahead of the election…
But as they say “There is more than one way to skin a cat”
In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. |
03/15/2024
4:22 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:46 PM | Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:47 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:17 PM | Blueprint Medicines (Subject)
Lee Philina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
5:24 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:26 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:27 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:28 PM | Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:29 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:15 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:18 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:19 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:20 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:21 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:23 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:22 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:15 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:16 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:17 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:18 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:19 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:21 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
9:41 AM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:19 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
2:06 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:03 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
7:20 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:40 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
4:26 PM | Blueprint Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:05 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:54 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:35 AM | Blueprint Medicines (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/29/2024
5:13 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Blueprint Medicines (Subject)
| Form SC 13G/A | |
01/10/2024
9:16 AM | Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024
7:03 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:24 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
2:56 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:09 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
7:45 PM | Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
12:17 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free BPMC Stock Alerts